文献速递儿科影像技术与安全CT

标准CT定量儿童及青少年淋巴瘤化疗相关体成分变化

Quantification of chemotherapy-induced changes in body composition in pediatric, adolescent, and young adult lymphoma using standard of care CT imaging.
PubMed 文献 · Eur Radiol · 2022-08-10

本研究回顾性纳入110例儿童、青少年及年轻成人淋巴瘤患者,利用标准低剂量CT手动分割L3层面骨骼肌、皮下及内脏脂肪体积,比较基线至首次治疗随访的体成分变化与BMI百分位变化。CT显示SAT和VAT显著增加、SkM显著减少,而BMI%无变化且与CT体成分变化无显著相关。男性、<12岁、非霍奇金淋巴瘤及III-IV期患者脂肪增加和肌肉减少更明显。

要点

  • 低剂量CT可定量化疗引起的体成分变化,BMI无法反映这些变化。
  • L3层面连续5层轴位CT手动分割用于评估SkM、SAT和VAT体积。
  • 男性、<12岁、非霍奇金淋巴瘤及III-IV期患者体成分变化更显著。

关键影像表现/征象

  • 从基线至首次随访,SAT和VAT体积显著增加,SkM体积显著减少。
  • BMI百分位从基线至首次随访无显著变化,且与CT体成分变化无显著相关。
  • 男性、<12岁、非霍奇金淋巴瘤及III-IV期患者脂肪增加和肌肉减少更明显。

临床应用与阅片要点

  • 对儿童及青少年淋巴瘤患者,可利用标准低剂量CT在L3层面评估体成分变化。
  • BMI正常不能排除治疗相关的体成分改变,报告时可提示CT体成分定量价值。
  • 对男性、<12岁、非霍奇金淋巴瘤及III-IV期患者,可关注脂肪增加和肌肉减少。

局限性

  • 回顾性单中心设计,样本量110例。
  • 体成分分割为手动操作,未报告观察者间一致性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The objective of this study was to use computed tomography (CT) imaging to quantify chemotherapy-induced changes in body composition (BC) in pediatric, adolescent, and young adult (AYA) patients with lymphoma and to compare image-derived changes in BC measures to changes in traditional body mass index (BMI) measures.

METHODS: Skeletal muscle (SkM), subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) volumes were manually segmented using low-dose CT images acquired from a 10-year retrospective, single-site cohort of 110 patients with lymphoma. CT images and BMI percentiles (BMI%) were acquired from baseline and first therapeutic follow-up. CT image segmentation was performed at vertebral level L3 using 5 consecutive axial CT images.

RESULTS: CT imaging detected significant treatment-induced changes in BC measures from baseline to first follow-up time points, with SAT and VAT significantly increasing and SkM significantly decreasing. BMI% measures did not change from baseline to first follow-up and were not significantly correlated with changes in image-derived BC measures. Patients who were male, younger than 12 years old, diagnosed with non-Hodgkin's lymphoma, and presented with stage 3 or 4 disease gained more adipose tissue and lost more SkM in response to the first cycle of treatment compared to their clinical counterparts.

CONCLUSIONS: Standard of care CT imaging can quantify treatment-induced changes in BC that are not reflected by traditional BMI assessment. Image-based monitoring of BC parameters may offer personalized approaches to lymphoma treatment for pediatric and AYA patients by guiding cancer treatment recommendations and subsequently enhance clinical outcomes.

KEY POINTS: • Standard of care low-dose CT imaging quantifies chemotherapy-induced changes in body composition in pediatric, adolescent, and young adults with lymphoma. • Body mass index could not detect changes in body composition during treatment that were quantified by CT imaging. • Pediatric and AYA patients who were male, younger than 12 years old, and diagnosed with non-Hodgkin's lymphoma, and presented with stage 3 or 4 disease gained more adipose tissue and lost more skeletal muscle tissue in response to the first cycle of treatment compared to their clinical counterparts.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Tram, Chou, Ettefagh, et al. Quantification of chemotherapy-induced changes in body composition in pediatric, adolescent, and young adult lymphoma using standard of care CT imaging. Eur Radiol. 2022. PMID: 35947147. doi:10.1007/s00330-022-09048-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。